Proteinuria and hypertension.
Ritz E, Nowicki M, Fliser D, Hörner D, Klimm HP.
Kidney Int Suppl. 1994 Nov;47:S76-80.
Nephrosclerosis and hypertension.
Ono H, Ono Y.
Med Clin North Am. 1997 Nov;81(6):1273-88. doi: 10.1016/s0025-7125(05)70582-4.
Malignant or accelerated hypertension.
Vaziri ND.
West J Med. 1984 Apr;140(4):575-82.
[Hypertensive nephrosclerosis].
Krummel T, Bazin D, Faller AL, Hannedouche T.
Presse Med. 2012 Feb;41(2):116-24. doi: 10.1016/j.lpm.2011.04.008. Epub 2011 Jun 8.
Time-averaged proteinuria during follow-up and renal prognosis in patients with biopsy-proven benign nephrosclerosis.
Amano H, Koike K, Haruhara K, Tsuboi N, Ogura M, Yokoo T.
Clin Exp Nephrol. 2020 Aug;24(8):688-695. doi: 10.1007/s10157-020-01885-w. Epub 2020 Apr 9.
Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis.
Sumida K, Hoshino J, Ueno T, Mise K, Hayami N, Suwabe T, Kawada M, Imafuku A, Hiramatsu R, Hasegawa E, Yamanouchi M, Sawa N, Fujii T, Ohashi K, Takaichi K, Ubara Y.
PLoS One. 2016 Jan 25;11(1):e0147690. doi: 10.1371/journal.pone.0147690. eCollection 2016.
Renal insufficiency in nephrosclerosis (benign nephrosclerosis resp. transition from benign to secondary malignant nephrosclerosis) correlations between morphological and functional parameters.
Grund KE, Mackensen S, Grüner J, Neunhoeffer J, Bader H, Bohle A.
Klin Wochenschr. 1978 Dec 1;56(23):1147-54. doi: 10.1007/BF01476858.
Renal ablation acutely transforms 'benign' hypertension to 'malignant' nephrosclerosis in hypertensive rats.
Bidani AK, Griffin KA, Plott W, Schwartz MM.
Hypertension. 1994 Sep;24(3):309-16. doi: 10.1161/01.hyp.24.3.309.
Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
Innes A, Johnston PA, Morgan AG, Davison AM, Burden RP.
Q J Med. 1993 Apr;86(4):271-5.
"Benign" hypertensive nephrosclerosis.
Dasgupta I, Porter C, Innes A, Burden R.
QJM. 2007 Feb;100(2):113-9. doi: 10.1093/qjmed/hcl139. Epub 2007 Jan 23.
